In contrast to these studies, a majority of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) showed increased expression of FcγRIIb on monocytes and B cells after IVIg treatment (32). This evidence concerns the gene FCGR2B and chronic inflammatory demyelinating polyradiculoneuropathy.